T/CI 018-2022 Active Group standards

T/CI 018-2022 Dogs' Rapid External Diagnostic Technology Guide (Fluorescent Immuno-chromatographic Method)

Publish Date: 2022-03-21 Implement Date: 2022-03-21 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 30

Basic Information

Standard Code: T/CI 018-2022

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Animal husbandry and breeding

Publish Date: 2022-03-21

Implement Date: 2022-03-21

Pages: 12 pages

Scope

Scope: This guideline specifies the experimental condition requirements, experimental design, implementation and verification of rapid in vitro diagnostic techniques for dogs, as well as technical requirements such as related instruments and detection principles. This guideline can be used as a reference document for detecting corresponding physiological or pathological indicators in dogs, and is suitable for relevant testing personnel in research and development units of rapid in vitro diagnostic techniques for dogs, pet hospitals, third-party testing centers, and pet grooming salons. Main technical content: 3.1 In vitro diagnosis In vitro diagnosis (IVD) refers to obtaining clinical diagnostic information and data on diseases or body functions by testing human or animal samples (blood, body fluids, excrement, tissues, etc.) outside the human or animal body, thereby determining the status of diseases or body functions. In vitro diagnostic products are mainly composed of diagnostic equipment (instruments) and diagnostic reagents. 3.2 Lateral flow immunoassay Lateral flow immunoassay (LFIA) is a rapid detection technology combining the specific immune reaction between antigens and antibodies with chromatography technology. Its principle is that the sample to be tested flows through the test zone under siphoning action. During the lateral flow process, the sample to be tested specifically binds to the bioactive materials (such as antigens, antibodies, nucleic acid conjugates, etc.) on the binding pad and chromatography membrane, forming detectable (or visible to the naked eye) detection lines and quality control lines on the chromatography membrane. Lateral flow immunoassay can be divided into two detection methods according to the size of the detection molecules and the detection principle: one is the direct method, namely the double antibody sandwich method, which is mainly used to detect biomolecules with multiple antigen epitopes; the other is the comp